Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase
Deborah Cardinali(Sapienza University of Rome), Sabina Chiaretti(Sapienza University of Rome), Antonino Mulè(Università Cattolica del Sacro Cuore), Michela Ansuinelli(Sapienza University of Rome), Renato Bassan(Pittini Group (Italy)), Mariangela Di Trani(Sapienza University of Rome), Robin Foà(Sapienza University of Rome), Mattia Cola(Sapienza University of Rome), Marco Beldinanzi(Sapienza University of Rome), Marco De Gobbi(Ospedale San Luigi Gonzaga), Matteo Della Porta(University of Milan), Monia Lunghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Michele Cedrone(Azienda Ospedaliera San Giovanni Addolorata), Valeria Cardinali(Azienda Ospedaliera di Perugia), Mariacarla De Simone, Irene Della Starza(Associazione Italiana Ematologia Oncologia Pediatrica), Tamara Intermesoli(University of Bergamo), Prassede Salutari(Azienda USL di Pescara), Anna Guarini(Sapienza University of Rome), Nicola Stefano Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Caterina Alati(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Mabel Matarazzo(Sapienza University of Rome), Loredana Elia(Sapienza University of Rome), Vittorio Bellomarino(Sapienza University of Rome)
Cited by 1
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553